2025-07-15 - Analysis Report
Okay, here's a report analyzing Eli Lilly and Co. (LLY) based on the data you provided.

## Eli Lilly and Co. (LLY) Stock Analysis

**Company Overview:** Eli Lilly and Co. is a global pharmaceutical company that discovers, develops, manufactures, and markets pharmaceutical products.

### 1. Performance vs. S&P 500 (VOO)

*   **LLY Cumulative Return:** 259.73%
*   **VOO Cumulative Return:** 95.85%
*   **Absolute Outperformance:** 159.7%
*   **Relative Outperformance:** 55.2 (This indicates LLY's outperformance is in the upper range of its historical volatility against the S&P 500).

**Analysis:** LLY has significantly outperformed the S&P 500. The relative outperformance suggests this isn't just a recent phenomenon, but rather LLY has consistently delivered strong returns relative to the broader market, positioning it favorably within its historical range of outperformance.

**Alpha and Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha   | Beta   | Cap (B) |
|------------|--------|--------|---------|--------|---------|
| 2015-2017  | 10.0%  | 56.3%  | -19.0%  | 0.0    | 75.8    |
| 2016-2018  | 39.0%  | 58.6%  | 21.0%   | -0.1   | 103.9   |
| 2017-2019  | 50.0%  | 58.6%  | 20.0%   | 0.3    | 118.0   |
| 2018-2020  | 52.0%  | 58.6%  | 33.0%   | 0.1    | 151.6   |
| 2019-2021  | 106.0% | 60.6%  | 57.0%   | 0.2    | 248.0   |
| 2020-2022  | 98.0%  | 64.8%  | 96.0%   | 0.2    | 328.4   |
| 2021-2023  | 133.0% | 64.8%  | 115.0%  | 0.3    | 523.3   |
| 2022-2024  | 150.0% | 72.2%  | 124.0%  | 0.2    | 693.0   |
| 2023-2025  | 113.0% | 76.8%  | 65.0%   | 0.2    | 717.6   |

**Analysis:**

*   **CAGR:**  Shows impressive growth, especially in recent periods.
*   **MDD:**  Maximum Drawdown indicates periods of significant price decline. While high, the strong CAGR suggests LLY recovers well.
*   **Alpha:**  Consistently positive, indicating LLY generates returns above what would be expected based on market movements alone.  The recent years show substantial alpha generation.
*   **Beta:**  Beta is relatively low, suggesting LLY is less volatile than the overall market.
*   **Cap (B):** Consistently growing market capitalization indicates confidence in this stock.

### 2. Recent Stock Price Movement

*   **Current Price:** $799.34
*   **Previous Close:** $793.01
*   **Change:** 0.8%
*   **5-Day Moving Average:** $791.07
*   **20-Day Moving Average:** $786.06
*   **60-Day Moving Average:** $782.05

**Analysis:** LLY is trading above its 5, 20, and 60-day moving averages, signaling a positive short-term trend. The price increase from the previous close suggests momentum, likely driven by the news and events highlighted below.

### 3. Market Risk Indicators and Expected Return

*   **Market Risk Indicator (MRI):** 0.3372 (Low Risk)
*   **RSI:** 65.79 (Approaching overbought territory)
*   **PPO:** 0.1372
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.34)
*   **Recent (20-day) Relative Divergence Change:** 1.0 (+) indicates short-term upward momentum
*   **Expected Return:** 132.6% (Long-term, relative to S&P 500)

**Analysis:**

*   The MRI indicates a low level of perceived risk, which is generally positive.
*   The RSI suggests that the stock might be approaching overbought conditions. A reading above 70 typically indicates that a stock may be overvalued and due for a correction.
*   The PPO value shows the stock's recent performance relative to its past performance.
*   The Hybrid Signal recommends allocating 80% of available cash to buy the stock with caution, aligning with the MRI indicator of low risk.
*   The positive recent divergence confirms the current upward trend.
*   The high expected return (132.6%) is significant and suggests strong confidence in LLY's long-term growth potential.

The fact that the 'change' is 0.8% indicates a recent price movement that is worth noting but not extreme. If it were much higher (e.g., 5% or more), it would suggest a stronger reaction to the news or events.

### 4. Recent News & Significant Events

*   **[2025-07-11]:** Major business developments, regulatory changes, or market events.
*   **[2025-07-15]:** Analysts discussing performance and outlook.
*   **[2025-07-13]:** Notable stock volatility.
*   **[2025-07-12]:** Market experts highlighting risks and opportunities.

**Analysis:** The news suggests a dynamic environment for LLY, with recent events driving both analyst attention and stock volatility. This emphasizes the need for continued monitoring of company announcements and market developments.

### 5. Recent Earnings Analysis

| Date       | EPS  | Revenue     |
|------------|------|-------------|
| 2025-05-01 | 3.07 | 12.73 B$ |
| 2024-10-30 | 1.08 | 11.44 B$ |
| 2024-08-08 | 3.29 | 11.30 B$ |
| 2024-04-30 | 2.49 | 8.77 B$ |
| 2025-05-01 | 2.49 | 8.77 B$ |

**Analysis:** The provided data shows a general uptrend in both EPS (Earnings Per Share) and Revenue. The significant jump in revenue from 8.77B$ to 12.73B$ is particularly noteworthy and could be a key driver of recent stock performance.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
|------------|-----------|---------------|
| 2025-03-31 | $12.73B   | 82.53%        |
| 2024-12-31 | $13.53B   | 82.24%        |
| 2024-09-30 | $11.44B   | 81.02%        |
| 2024-06-30 | $11.30B   | 80.80%        |
| 2024-03-31 | $8.77B    | 80.91%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE      |
|------------|-----------|----------|
| 2025-03-31 | $15.76B   | 17.50%   |
| 2024-12-31 | $14.19B   | 31.07%   |
| 2024-09-30 | $14.24B   | 6.81%    |
| 2024-06-30 | $13.56B   | 21.88%   |
| 2024-03-31 | $12.81B   | 17.51%   |

**Analysis:**

*   **Revenue:** Shows strong growth over the past year.
*   **Profit Margin:**  Consistently high, indicating strong operational efficiency and pricing power.
*   **Equity:**  Growing equity base demonstrates financial strength.
*   **ROE:**  Return on Equity is volatile but generally strong, reflecting efficient use of shareholder investments.

### 7. Overall Summary

LLY demonstrates strong financial health and has significantly outperformed the S&P 500. Recent earnings data show strong revenue and EPS growth, supported by high-profit margins and a growing equity base. While the RSI suggests the stock is approaching overbought conditions, the overall outlook remains positive. The recent news highlights increased market attention and potential volatility, warranting careful monitoring. The exceptionally high expected return of 132.6% suggests that analysts have a very bullish outlook on the stock's long-term potential. The recent Hybrid signal of buying 80% of cash further underscores this positive sentiment, albeit with a note of caution due to ongoing market volatility.
